These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22390562)

  • 21. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?
    Antonioli L; Fornai M; Colucci R; Tuccori M; Blandizzi C
    Expert Opin Investig Drugs; 2011 Jun; 20(6):717-21. PubMed ID: 21506907
    [No Abstract]   [Full Text] [Related]  

  • 23. Adenosine receptors and inflammation.
    Blackburn MR; Vance CO; Morschl E; Wilson CN
    Handb Exp Pharmacol; 2009; (193):215-69. PubMed ID: 19639284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel trends in the treatment of cardiovascular disorders: site- and event- selective adenosinergic drugs.
    Szentmiklósi AJ; Cseppento A; Harmati G; Nánási PP
    Curr Med Chem; 2011; 18(8):1164-87. PubMed ID: 21291368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors.
    Peralta C; Hotter G; Closa D; Prats N; Xaus C; Gelpí E; Roselló-Catafau J
    Hepatology; 1999 Jan; 29(1):126-32. PubMed ID: 9862858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease.
    Force T; Kuida K; Namchuk M; Parang K; Kyriakis JM
    Circulation; 2004 Mar; 109(10):1196-205. PubMed ID: 15023894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of adenosine receptors in rheumatoid arthritis.
    Varani K; Padovan M; Govoni M; Vincenzi F; Trotta F; Borea PA
    Autoimmun Rev; 2010 Dec; 10(2):61-4. PubMed ID: 20691813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects.
    Villarreal F; Zimmermann S; Makhsudova L; Montag AC; Erion MD; Bullough DA; Ito BR
    Mol Cell Biochem; 2003 Sep; 251(1-2):17-26. PubMed ID: 14575299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs targeting adenosine signaling pathways: A current view.
    Kutryb-Zając B; Kawecka A; Nasadiuk K; Braczko A; Stawarska K; Caiazzo E; Koszałka P; Cicala C
    Biomed Pharmacother; 2023 Sep; 165():115184. PubMed ID: 37506580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease.
    Wernly B; Zhou 周稚超 Z
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H723-H729. PubMed ID: 32822211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of adenosine receptors in the vasculature.
    Tabrizchi R; Bedi S
    Pharmacol Ther; 2001 Aug; 91(2):133-47. PubMed ID: 11728606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine: a modulator of the cardiac response to stress.
    Chen Y; Bache RJ
    Circ Res; 2003 Oct; 93(8):691-3. PubMed ID: 14563707
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenosine in the mammalian heart: nothing to get excited about.
    Pelleg A; Kutalek SP
    Trends Pharmacol Sci; 1997 Jul; 18(7):236-8. PubMed ID: 9253854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Cardiovascular Therapeutics. Cambridge, MA, USA, June 10-11, 2003.
    Zavoico GB
    Cardiovasc Drug Rev; 2003; 21(3):246-53. PubMed ID: 14582482
    [No Abstract]   [Full Text] [Related]  

  • 35. Adenosine: an old drug newly discovered.
    Eltzschig HK
    Anesthesiology; 2009 Oct; 111(4):904-15. PubMed ID: 19741501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More about adenosine and arrhythmias.
    Tomcsányi J; Tenczer J; Jobbágy L
    Cardiovasc Res; 1997 Jun; 34(3):603-5. PubMed ID: 9231045
    [No Abstract]   [Full Text] [Related]  

  • 37. Special Issue: Adenosine Receptors.
    Ciruela F; Sotelo E
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28726742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Ways of Targeting the Adenosine/Adenosine Receptor Axis in Lung Inflammation and Injury.
    Majetschak M
    Crit Care Med; 2016 Apr; 44(4):853-4. PubMed ID: 26974452
    [No Abstract]   [Full Text] [Related]  

  • 39. Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights.
    Sarkar A; Fanous KI; Marei I; Ding H; Ladjimi M; MacDonald R; Hollenberg MD; Anderson TJ; Hill MA; Triggle CR
    Vasc Health Risk Manag; 2024; 20():255-288. PubMed ID: 38919471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine signaling as target in cardiovascular pharmacology.
    Antonioli L; Fornai M; Pellegrini C; Pacher P; Haskó G
    Curr Opin Pharmacol; 2023 Aug; 71():102393. PubMed ID: 37450948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.